Application of Existing and Emerging Biomarkers for Immuno-Oncology Across Tumor Types
August 28th, 2020
Learn from the experts including Dr. John Marshall, Dr. Jamie Chaft, MD and Scot Niglio, MD, about current and emerging immuno-oncology biomarkers to guide selection of optimal cancer treatment across tumor types. Participate in the interactive CCO Webinar or watch the on-demand Webcast and download the slides. Listen to a podcast for answers to FAQs asked during the live Webinar.
No-Visitor Policies Are Bad Medicine
August 26th, 2020
According to Dr. John Marshall, “Cancer care is not elective; it has to keep going. One of the worst policies for our patients right now is this no-visitor policy. You are coming for a treatment, a clinic visit, or, worse yet, admitted to the hospital for end-of-life care or for some complex medical procedure related to your cancer, and yet you can’t have a caregiver, an advocate, sitting next to you in your room.”
Glimmers of Hope- New Strategies for Overcoming Treatment Resistance in Patients with BRAF-V600E-Mutated Metastatic Colorectal Cancer
August 18th, 2020
BRAF V600E-mutated metastatic colorectal cancer is notoriously difficult to treat due to an aggressive tumor biology and resistance to chemotherapy.
Meet PanCan Research Grantee: Jill Smith, MD
August 18th, 2020
Jill Smith, MD, has a message for patients with pancreatic cancer: “Never lose hope, be strong and be encouraged.” Smith, a clinician-scientist and professor of medicine at Georgetown University and a member of the Georgetown Lombardi Comprehensive Cancer Center, tries to model those tenets herself.
Justice Ruth Bader Ginsburg says she is being treated for recurrence of cancer
July 20th, 2020
“The treatment she is getting is typical for pancreatic cancer. That would fit,” said John L. Marshall, director of the Ruesch Center for the Cure of Gastrointestinal Cancers at Georgetown Lombardi Comprehensive Cancer Center. “But her cancer history is very unusual, from a good perspective. She’s always done much better than one would have anticipated.”
